PRESS RELEASE
1 December 2022

Holland & Knight Health Dose: November 29, 2022

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress Returns for Lame-Duck Push
  • House Democrats to Vote on Leadership, Caucus Rules This Week
  • Medicare Prior Authorization Transparency Bill Introduced in Senate
  • ARPA-H Launches Website and Twitter Account
  • HHS Plan to Fund New COVID-19 Vaccine Initiative; GOP Leaders Oppose
  • Senators Move to Advance Legislation to Improve Dual-Eligible Care
  • HHS Proposes Changes to Substance Use Disorder Patient Record Protections
  • HHS Overhauls 340B Administrative Dispute Resolution Process
  • Monkeypox Renamed "Mpox" in Effort to Reduce Stigma

Read the full Health Dose ยป

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More